MedPath

西藏海金药业有限公司

Ownership
-
Established
2015-06-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Carboprost Tromethamine Injection

Product Name
卡前列素氨丁三醇注射液
Approval Number
国药准字H20254274
Approval Date
May 27, 2025
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20253593
Approval Date
Mar 11, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.